Pricing - HEOR - Access
Our market access related courses aim to accelerate your learning curve in disciplines that are critical in the process of optimising market access, and even patient access.
Get up to speed in no time with CELforPharma’s 1- & 2-day courses with international industry experts in:
➙ Market Access in Europe
➙ Market Access in the US
➙ Value Pricing
➙ Real World Evidence
➙ Health Economics
➙ Health Technology Assessment
Understanding Pharma Market Access & Payers in Europe
With Dr. Nick Proctor
In this 1-day course, you will learn:
The patterns in pricing & reimbursement systems and processes in France, Germany, Italy, Spain and the UK.
Payer archetypes and the drivers of their decision-making processes
The market access plan and process, and the contributions of internal stakeholders across functions.
...
Understanding Pharma Market Access in the US
With Dr. Nick Proctor & Louisa Oliver Byrne
In this 1-day course, you will learn:
The structure and key players of US Managed Care systems, and how they compare with other global systems.
The scope of medical benefit and how to navigate the pricing and access control mechanisms in this system.
The role and significance of Pharmacy Benefit Managers (PBMs) and how to navigate the pricing and access control mechanisms in the pharmacy benefit system.
...
How to Price Better Than Your Competitors for Successful Market Access
Essential Insights, Principles & Techniques
With Gary Johnson & Sam Johnson
In this 2-day course, you will learn:
An overview of payer types and of national pricing & market access systems around the world.
The concepts and language of pharma pricing and market access that confuse many executives.
Evidence-based research techniques for getting the most accurate feedback from payers about your product’s profile.
...
Generating RWE for Optimising Market/Patient Access
With Prof. Dr. Thomas Wilke
In this 1-day course, you will learn:
The expectations of external stakeholders regarding RWE along the product lifecycle
The fundamental concepts, methodologies and research techniques of RWE in the context of optimising Market Access
Critical success factors of a RWE study
...
Learn the Fundamentals of Health Economics
With Prof. Dr. Lieven Annemans
The logic and math behind QALYs, ICERs, decision-trees and Markov models.
How external stakeholders use and challenge health economic evidence.
Key principles of cost-effectiveness analysis and Budget Impact Analysis.
...
During a 2-day Face-to-Face Course:
Health Economics for Non-Health-Economists
OR
In an Online Self-Study Programme:
Basics of Health Economics
Critical New HTA Developments in Europe: Challenges & Solutions
With Prof. Dr. Lieven Annemans
In this 1-day course, you will learn:
The different types of HTAs in Europe.
How to address the broad and evolving array of assessment criteria in Europe.
How to optimise clinical evidence generation for HTA bodies.
How to use Real World Data for HTA purposes.
How to prepare for the new Joint Clinical Assessment (JCA) in the EU.
Are you ready to take your career in the pharmaceutical industry to the next level?
Discover CELforPharma's complete course portfolio, including topics you work on in cross-functional teams: